The umbilical cord connects the baby with the placenta and the mother. Three vessels pass through the umbilical cord, surrounded by Wharton’s jelly – a transparent, gelatinous matter. The vessels supply the baby with oxygenated, nutrient-rich blood from the placenta.
Umbilical tissue cells have great therapeutic and biotechnological potential: they replace damaged or non-functioning cells.
Umbilical tissue is a rich source of mesenchymal stem cells capable of differentiating into a wide range of tissue, such as bone, cartilage, tendons, muscles, nerves or liver. These cells can also be found in cord blood, although to a much lesser extent, as well as in placental tissue.
Mesenchymal stem cells are probably the most promising type of cells for cell therapy, recovery treatment of damaged organs and treatment of various diseases.
Research results have demonstrated that their immunosuppressive and immunomodulatory properties may be used in the treatment of chronic inflammatory and autoimmune processes.
Why choose umbilical cord tissue collection?
- It contains a large number of mesenchymal stem cells that are used in clinical trials for treatment in the field of regenerative medicine and tissue engineering
- Its cells have been used in clinical trials for the treatment of neurological, rheumatological, autoimmune and other diseases, such as Alzheimer’s and Parkinson’s disease, autism, osteoarthritis, psoriasis, lupus or stroke1
- Together with the collection of umbilical cord blood, you can store a wider range of stem cells for the benefit of your baby for various therapeutic uses
- It is stored in several cryovials, which enables multiple use
Currently, there are more than 200 clinical trials registered for verification of the potential use of umbilical tissue, for example in the treatment of neurological, autoimmune and other diseases.1
Use of umbilical cord tissue